Tamsulosin recalls
The FDA has published 3 recalls involving Tamsulosin since 2015. The latest was reported on 21 Aug 2019. Most were for potency & assay. Wockhardt Usa has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls3since 2015
Last 12 months0reported
Class I00% of total
Ongoing0latest 21 Aug 2019
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 3 100%Class III 0 0%
Why tamsulosin is recalled
Companies
By year
All tamsulosin recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Tamsulosin Hydrochloride Capsules, USP 4 mg recalledTamsulosin Hydrochloride | Macleods Pharma Usa | Potency & Assay | Nationwide |
| Drug | CLASS II | Tamsulosin Hydrochloride Capsules, USP, 4 mg recalledTamsulosin Hydrochloride | Ascend Laboratories | Potency & Assay | Nationwide |
| Drug | CLASS II | Tamsulosin Hydrochloride Capsules, USP* recalled by Wockhardt Usa | Wockhardt Usa | Manufacturing (CGMP) Deviations | Nationwide |
Should you stop taking Tamsulosin?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.